Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.61 -0.03 (-1.83%)
At close: Sep 29, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Current Leases (2019)

Updated

Chemomab Therapeutics' Current Leases was $505,000 in Q3 2019, up 4.3% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Current Leases (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Chemomab Therapeutics 11.80 Mn 11.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 505,000.00
Jun 30, 2019 484,000.00
API Access

Chemomab Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CMMB&period=max&api_key=YOUR_API_KEY